BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150
42 results:

  • 1. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
    Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
    Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
    Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation.
    Georgantzoglou N; Green D; Winnick KN; Sumegi J; Charville GW; Bridge JA; Linos K
    Genes Chromosomes Cancer; 2022 Aug; 61(8):471-480. PubMed ID: 35289445
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Response to ALK-TKIs in a lung adenocarcinoma patient harboring dual dctn1-ALK and ALK-CLIP4 rearrangements.
    Gao F; Gao F; Wu H; Lu J; Xu Y; Zhao Y
    Thorac Cancer; 2022 Apr; 13(7):1088-1090. PubMed ID: 35212154
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Spitz nevus with EHBP1-ALK fusion and distinctive membranous localization of ALK.
    Bahrani E; Kunder CA; Teng JM; Brown RA; Rieger KE; Novoa RA; Cloutier JM
    J Cutan Pathol; 2022 Jun; 49(6):584-588. PubMed ID: 35113459
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and dctn1-ALK fusion.
    Yin Q; Guo T; Zhou Y; Sun L; Meng M; Ma L; Wang X
    Thorac Cancer; 2022 Feb; 13(4):637-642. PubMed ID: 34964276
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
    Wang B; Chen R; Wang C; Guo J; Yuan M; Chen H; Xia X; Zhong D
    Hum Pathol; 2021 Aug; 114():90-98. PubMed ID: 34019866
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. dctn1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
    Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
    Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature.
    Kazlouskaya V; Ho J; Jedrych J; Karunamurthy A
    J Cutan Pathol; 2021 Jul; 48(7):837-841. PubMed ID: 33217002
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions.
    Cohen JN; Yeh I; Jordan RC; Wolsky RJ; Horvai AE; McCalmont TH; LeBoit PE
    Am J Surg Pathol; 2018 Sep; 42(9):1133-1142. PubMed ID: 30001233
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.
    Saraggi D; Salmaso R; Zamuner C; Munari G; Lanza C; Alaibac MS; Bassetto F; Rugge M; Montesco MC; Cerroni L; Fassan M
    J Am Acad Dermatol; 2018 Oct; 79(4):728-735. PubMed ID: 29920315
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults.
    Suzuki Y; Yano T; Suehiro Y; Iwasaki H; Hidaka M; Otsuka M; Sunami K; Inoue N; Sawamura M; Ito T; Iida H; Nagai H
    Int J Hematol; 2018 Aug; 108(2):161-166. PubMed ID: 29605873
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.
    Dickson BC; Swanson D; Charames GS; Fletcher CD; Hornick JL
    Mod Pathol; 2018 May; 31(5):753-762. PubMed ID: 29327718
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
    Vendrell JA; Taviaux S; Béganton B; Godreuil S; Audran P; Grand D; Clermont E; Serre I; Szablewski V; Coopman P; Mazières J; Costes V; Pujol JL; Brousset P; Rouquette I; Solassol J
    Sci Rep; 2017 Oct; 7(1):12510. PubMed ID: 28970558
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States.
    Coutinho AD; Makenbaeva D; Farrelly E; Landsman-Blumberg PB; Lenihan D
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):676-683. PubMed ID: 28729178
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The "Wedge Sign": An Imaging Sign for Aggressive Lacrimal Gland Disease.
    Lorenzano D; Rose GE
    Ophthalmology; 2017 Jul; 124(7):1081-1083. PubMed ID: 28372859
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.
    Herold T; Gökbuget N
    Curr Oncol Rep; 2017 May; 19(5):31. PubMed ID: 28361222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
    JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.